Drug details:
Molecular formula: C₂₅H₂₆N₄O₅

Standard name: [2-[[(1R,2R)-2-methylcyclohexyl]carbamoylamino]-2-oxoethyl] 4-oxo-3-phenylphthalazine-1-carboxylate

Curated SMILES: C[C@@H]1CCCC[C@H]1NC(=O)NC(=O)COC(=O)C1=NN(C2=CC=CC=C2)C(=O)C2=C1C=CC=C2

Evidence for compound's anti-virulence activity:

Shigella
Related VF: TTSS (Type III secretion system)
Target: Spa47; IpaC
Drug effect: Inhibits transcriptional activator.
Max phase: Preclinical (in vivo)
Publication:
Case HB, et al., 2020. Novel Noncompetitive Type Three Secretion System ATPase Inhibitors Shut Down Shigella Effector Secretion. Biochemistry 59(28):2667-2678.